Value-Based Contracting

CMS under the Trump administration is pushing VBC in two directions at once: tightening Medicare Advantage payment advantages and Star Ratings exposure while expanding or refining model-based risk through ACO and specialty-payment designs such as LEAD, ACCESS, TEAM, and the Increasing Organ Transplant Access Model. The week’s through-line is that value-based contracting is becoming more operationally demanding—ACO participants need stronger data infrastructure, care management, and risk analytics, while payers continue to defend VBC as the cost-control strategy despite growing scrutiny over MA coding, quality bonuses, and AI-enabled utilization management. For providers and ACOs, the strategic question is shifting from whether to enter VBC to how to manage model complexity, benchmark risk, and technology governance as CMS recalibrates incentives across MA and traditional Medicare models (HFMA on MA payment changes; [Aledade on the LEAD model](https://news.google.com/rss/articles/CBMiggFBVV95cUxQMjMwak1tRDRZS2lVam5pcXNYd2IxVS1ROWpGYXdGS2RYQUZwNUNYSExIZ092Z092bFMyV0dfNld0QV9rbG5GZnNkbmxXWENPQVZwUWxKbkF6Z09pWHg0